ArticleHuman psychopharmacology2025

Efficacy of Intranasal Esketamine in Treatment-Resistant Depression: A Six-Month Real-World Follow-Up Study of Depressive Symptoms, Hopelessness, and Suicide Risk.

Maurizio Pompili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.